Table 4.

Antitumor activity in evaluable patients (n = 16)

Best responseNo. patientsTumor typesReduction
Partial response4BreastComplete response in liver; stable disease in bone
Stomach↓32% in lymph nodes
Gastroesophageal
Ocular melanoma
Minor response3Mesothelioma↓23% in lymph nodes
Prostate↓30% in PSA
SCC H + N↓26% in lymph node
Stable disease7Prostate
Unknown 1°
Melanoma
Esophagus
Pancreas